Tyson Foods Inc., a leading global meat processor, has announced it will remove the "No Antibiotics Ever" label from select chicken products, reintroducing antibiotics not significant to human treatment. This policy shift has raised eyebrows, given the growing concern about antibiotic resistance fueled by food production practices.
Tyson Foods ditched the drug for infections eight years ago, and since then, the “no antibiotics ever” has been emblazoned on its chicken products’ label packaging. Then again, only some of the chicken items are set to lose the mentioned phrase on the label.
According to CNN Business, the Springdale, Arkansas-based food processing company will start using antibiotics in its chicken production and said that this is the type that is not important to the treatment of humans. In any case, the use of antibiotics in food production or processing has been heavily scrutinized in recent years because some bacteria have become resistant to medicines and treatment due to repeated exposure to antibiotics.
“At Tyson Foods, we base our decisions on sound science and an evolving understanding of the best practices impacting our customers, consumers, and the animals in our care,” the spokesperson of Tyson Foods said in a statement.
The company said that some of its chicken would start deleting the “no antibiotics important to human medicine” on the label by the end of this year. Tyson Foods ascertained it would only apply antibiotics that are up to the standard and recognized by the USDA and the World Health Organization (WHO).
It was in 2015 when the company announced its decision to eliminate the antibiotics in its chicken wings, breast, and chicken nuggets. At the time, the company said it was working to get rid of the drug as it was worried about the increase in antibiotic-resistant bacterial infections in humans. It added that it would like to play its part in helping reduce the human consumption of antibiotics.
Meanwhile, The Wall Street Journal was the first to report on Tyson Foods’ decision to resume its use of non-medically important antibiotics in some of its chicken production. “Based on current science, Tyson brand products are transitioning to No Antibiotics Important to Human Medicine (NAIHM), which is expected to be complete by the end of the calendar year,” the company’s representative stated.


SpaceX, Charter Communications Explore Mobile Partnership to Expand Starlink Wireless Service
Morgan Stanley Sees Chinese Auto Market Recovery Gaining Momentum in Late Summer
Nomura Stock Upgraded to Buy by BofA as Stronger ROE and Earnings Growth Boost Outlook
Asian Currencies Trade Mixed as Yen Hovers Near 40-Year Low, Dollar Holds Firm on Fed Outlook
Oil Prices Rebound as Strait of Hormuz Tensions Return After Ship Attack Near Oman
Japan Signals Preference for Low Interest Rates as BOJ Policy Debate Intensifies
Johns Hopkins University Lays Off 110 Employees as Federal Research Funding Declines
Gold Prices Rise Above $4,000 as Inflation Data and Weaker Dollar Boost Demand
Trump Threatens 100% Tariffs on Countries Imposing Digital Services Taxes on U.S. Tech Firms
Bank Regulation Rollbacks in the U.S. and UK Could Increase Financial Risks, Study Warns
Trump Orders DOJ Investigation Into Exxon, Chevron Over High Gas Prices
BOJ Hawk Signals Faster Interest Rate Hikes Amid Inflation Risks
OpenAI IPO Delay Weighs on SoftBank Shares as AI Valuation Concerns Grow
Doncasters Raises $919 Million in NYSE IPO as Aerospace Growth Accelerates
SK Hynix Targets $29.4 Billion Nasdaq Listing to Expand AI Chip Business
US Dollar Slips After PCE Inflation Data Eases Fed Rate Hike Expectations 



